DNAPrint genomics Ticker Symbol Changing to 'DNAG'
DNAPrint genomics Ticker Symbol Changing to 'DNAG'
Monday July 11, 1:02 pm ET



DNAPrint genomics, Inc. (OTC Bulletin Board: DNAP - News) today announced that commencing with the opening of the market on Tuesday, July 12, 2005, the Company's Common Stock will begin trading on the Over-the-Counter Bulletin Board under the symbol "DNAG."

The change of the symbol is the result of a stock consolidation approved by shareholders and the Board of Directors that also becomes effective the same day.

About DNAPrint genomics, Inc.

DNAPrint genomics, Inc. ( http://www.dnaprint.com ) is a developer of genomics-based products and services focused on drug development, pharmacogenomic diagnostic tests, forensics technology and consumer genetic tests. The Company's first theranostic product (drug/test combination) is PT- 401, a "Super EPO" (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients (end stage renal disease). Currently in pre- clinical development, PT-401 will be targeted to patients with a genetic profile indicating their propensity to have the best clinical response.



--------------------------------------------------------------------------------
Source: DNAPrint genomics
Biotech News

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech